18.07.2019
- Germany’s Boehringer Ingelheim has purchased AMAL Therapeutics for an undisclosed sum. AMAL is a private Swiss biotech that is focused on cancer immunotherapy and vaccines derived...
15.07.2019
- Swiss fine chemicals producer and drug developer Lonza has completed a $15 million multi-phase expansion at its site in Tampa, Florida, USA, adding solid oral dose development and...
02.07.2019
- Swiss fine chemicals producer and drug developer Lonza has signed a binding agreement to acquire a sterile drug product fill & finish plant from Novartis, the first such facility...
18.06.2019
- US drugs giant Pfizer is digging into its deep pockets to boost its oncology portfolio. The New York-based company said it will pay $48 per share to acquire Array BioPharma, a US...
17.06.2019
- German drugmaker Boehringer Ingelheim and Danish biotech Gubra have announced a second collaboration and license agreement to develop novel poly-agonist peptides to treat obesity...
13.06.2019
- US-based biotech Genomatica has acquired certain assets from REG Life Sciences (REG LS), a division of leading biofuels supplier Renewable Energy Group, boosting its ability to...
11.06.2019
- Canadian biotech company Phoenix Molecular Designs (PhoenixMD) and partner STA Pharmaceutical (WuXi STA), a Chinese contract development and manufacturing organization (CDMO), have...
04.06.2019
- Swiss fine chemicals company Lonza is carving out its specialty ingredients (LSI) segment under independent management, giving it increased control over operations and costs. LSI...
20.05.2019
- Bayer has broken ground for its new $150 million US cell culture technology center at Berkeley, California. The new facility will target biological therapies in particular in the...
08.05.2019
- Anglo-Swedish drugmaker AstraZeneca is to collaborate with French biotech Transgene, part of Institut Mérieux, to discover and develop immunotherapies for treating cancers and...